Holen Sie sich die Stockscreener-App
272.54
1.20%
3.23
Handel nachbörslich:
272.54
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LH?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$269.31
Offen:
$269.56
24-Stunden-Volumen:
532.06K
Relative Volume:
0.74
Marktkapitalisierung:
$22.65B
Einnahmen:
$12.71B
Nettoeinkommen (Verlust:
$435.50M
KGV:
52.92
EPS:
5.15
Netto-Cashflow:
$843.20M
1W Leistung:
+4.48%
1M Leistung:
+9.18%
6M Leistung:
+11.30%
1J Leistung:
+21.37%
1-Tages-Spanne:
$268.02
$272.66
1-Wochen-Bereich:
$258.36
$272.66
52-Wochen-Spanne:
$209.38
$283.47
Labcorp Holdings Inc Stock (LH) Company Profile
Firmenname
Labcorp Holdings Inc
Sektor
Branche
Telefon
(336) 229-1127
Adresse
358 S MAIN ST, BURLINGTON, NC
Vergleichen Sie LH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
272.54 | 22.38B | 12.71B | 435.50M | 843.20M | 5.15 |
|
TMO
Thermo Fisher Scientific Inc
|
484.79 | 180.28B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
209.14 | 147.31B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
663.92 | 52.18B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
120.29 | 33.33B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
190.23 | 31.60B | 15.50B | 1.33B | 2.16B | 7.34 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-04-02 | Eingeleitet | Redburn Atlantic | Buy |
| 2025-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-12-10 | Fortgesetzt | Jefferies | Buy |
| 2024-10-30 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-10-01 | Eingeleitet | Piper Sandler | Neutral |
| 2024-03-25 | Hochstufung | Argus | Hold → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Eingeleitet | Evercore ISI | In-line |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-09-19 | Herabstufung | Argus | Buy → Hold |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-01-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-01-11 | Hochstufung | Argus | Hold → Buy |
| 2021-01-11 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2021-01-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-07-14 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-13 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | Fortgesetzt | Deutsche Bank | Buy |
| 2020-05-15 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-04-29 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-04-27 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-04-27 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2019-07-16 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-06-21 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-04-02 | Hochstufung | Jefferies | Hold → Buy |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2019-01-03 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-10-30 | Herabstufung | Argus | Buy → Hold |
| 2018-10-25 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2018-10-19 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-06-07 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-05-01 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-03-23 | Eingeleitet | Argus | Buy |
Alle ansehen
Labcorp Holdings Inc Aktie (LH) Neueste Nachrichten
Labcorp CEO Schechter sells $1.5m in shares - Investing.com
LabCorp Scores Trial Victory in 401(k) Plan Fee Class Challenge - news.bloombergtax.com
Labcorp Holdings Sees RS Rating Rise To 73 - Investor's Business Daily
Labcorp Holdings: How Non-GAAP Adjustments Reveal a Stronger Earnings Story and a Potentially Undervalued Stock - AInvest
Investing in Labcorp Holdings (NYSE:LH) Five Years Ago Would Have Delivered You a 71% Gain - 富途牛牛
Analysts Have Conflicting Sentiments on These Healthcare Companies: Labcorp Holdings (LH), Bausch + Lomb Corporation (BLCO) and Radnet (RDNT) - The Globe and Mail
What analysts say about Labcorp Holdings Inc. stock outlookAlpha Focused Technical Trade Signals Gain Attention - beatles.ru
Hero Gum Debuts at New York Mets Game, Providing Fans Opportunity to Sign Up for Gift of Life Marrow Registry - GlobeNewswire Inc.
Is Labcorp Holdings Inc. a growth stock or a value stockDynamic portfolio growth - Jammu Links News
Is it the right time to buy Labcorp Holdings Inc. stockBuild your wealth with consistent stock growth - Jammu Links News
How strong is Labcorp Holdings Inc. company’s balance sheetHigh-yield growth strategies - Jammu Links News
How many analysts rate Labcorp Holdings Inc. as a “Buy”Free Investment Risk Control - Jammu Links News
Does Labcorp Holdings Inc. stock perform well during market downturnsCapitalize on high-yield stock opportunities - Jammu Links News
When is Labcorp Holdings Inc. stock expected to show significant growthHigh-margin investment plays - Jammu Links News
What is the dividend policy of Labcorp Holdings Inc. stockCapitalize on market trends early - Jammu Links News
What makes Labcorp Holdings Inc. stock price move sharplyBuild a diversified portfolio for maximum returns - Jammu Links News
What are Labcorp Holdings Inc. company’s key revenue driversFree Consultation - Jammu Links News
Gilliland, Labcorp director, sells $529k in stock - Investing.com
Gilliland, Labcorp director, sells $529k in stock By Investing.com - Investing.com Canada
LabCorp Holdings Director Gilliland Dwight Gary Sells 2000 Shares at $264.95/Share. - AInvest
Can a trend reversal in Labcorp Holdings Inc. lead to recoveryMomentum Based Equity Trading Plans Reviewed - metal.it
Labcorp Holdings (LH) Unveils Test Finder: AI Tool for Streamlined Lab Test Selection - Yahoo Finance
Labcorp Holdings: Top Momentum Stock for Long-Term Investors - AInvest
Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Advanced analytics toolkit walkthrough for Labcorp Holdings Inc.Buy Low Sell High Stock Watch Strategy in Focus - metal.it
The 5 Most Interesting Analyst Questions From Labcorp’s Q2 Earnings Call - Yahoo Finance
Labcorp Holdings (NYSE:LH) Is Paying Out A Dividend Of $0.72 - simplywall.st
Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search - MarketScreener
Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic - Yahoo Finance
Price Consolidation Hints at Upcoming Move in Labcorp Holdings Inc.Profit Focused Stock Screener Results Released - metal.it
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term - Yahoo Finance
Quest, Labcorp downplay ‘Big Beautiful Bill’ impact - Yahoo Finance
Breakthrough Cancer Test Gets EU Approval: New Hope for 2.7M European Cancer Patients Annually - Stock Titan
Should I hold or sell Labcorp Holdings Inc. stock in 2025Best Dividend Outlook For Consistent Profits - jammulinksnews.com
Labcorp’s SWOT analysis: diagnostics giant’s stock faces valuation scrutiny By Investing.com - Investing.com Nigeria
Labcorp’s SWOT analysis: diagnostics giant’s stock faces valuation scrutiny - Investing.com Australia
Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers – FTRE - FinancialContent
Gift of Life in Collaboration with Labcorp and DOUBLEMINT®, Launch Hero Gum to Expand Marrow Donor Registry - Yahoo Finance
How Efficient Is Labcorp Holdings Inc. at Controlling Operating CostsCapital Safe Stock Watchlist - metal.it
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MSN
What is the risk reward ratio of investing in Labcorp Holdings Inc. stockCapitalize on strong market momentum - Jammu Links News
Finanzdaten der Labcorp Holdings Inc-Aktie (LH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.32%
0.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):